Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease

被引:0
作者
Ronglin Wang
Fangfang Lu
Gang Zhu
Dayun Feng
Tiejian Nie
Kai Tao
Shaosong Yang
Jie Lei
Lu Huang
Zixu Mao
Qian Yang
机构
[1] The Fourth Military Medical University,Department of Neurosurgery, Tangdu Hospital
[2] Emory University School of Medicine,Departments of Pharmacology and Neurology
[3] GuangZhou Medical University,Department of Neurology
来源
Cell Death & Disease | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
MiRNAs, a group of powerful modulator of gene expression, participate in multiple cellular processes under physiological and pathological conditions. Emerging evidence shows that Drosha, which controls the initial step in canonical miRNA biogenesis, is involved in modulating cell survival and death in models of several diseases. However, the role of Drosha in Parkinson’s disease (PD) has not been well established. Here, we show that the level of Drosha decreases in 6-OHDA-induced cellular and animal models of PD. 6-OHDA induced a p38 MAPK-dependent phosphorylation of Drosha. This triggered Drosha degradation. Enhancing the level of Drosha protected the dopaminergic (DA) neurons from 6-OHDA-induced toxicity in both in vitro and in vivo models of PD and alleviated the motor deficits of PD mice. These findings reveal that Drosha plays a critical role in the survival of DA neurons and suggest that stress-induced destabilization of Drosha may be part of the pathological process in PD.
引用
收藏
相关论文
共 50 条
[41]   Necdin Prevents Loss of Dopaminergic Neurons in Experimental Parkinson's Disease [J].
Mochizuki, Hideki ;
Yasuda, Toru ;
Yoshikawa, Kazuaki ;
Mizuno, Yoshikuni .
NEUROTHERAPEUTICS, 2013, 10 (03) :542-542
[42]   Mechanism of toxicity in rotenone models of Parkinson's disease [J].
Sherer, TB ;
Betarbet, R ;
Testa, CM ;
Seo, BB ;
Richardson, JR ;
Kim, JH ;
Miller, GW ;
Yagi, T ;
Matsuno-Yagi, A ;
Greenamyre, JT .
JOURNAL OF NEUROSCIENCE, 2003, 23 (34) :10756-10764
[43]   MIRO1 mutation leads to metabolic maladaptation resulting in Parkinson's disease-associated dopaminergic neuron loss [J].
Zagare, Alise ;
Sauter, Thomas ;
Barmpa, Kyriaki ;
Pacheco, Maria ;
Kruger, Rejko ;
Schwamborn, Jens Christian ;
Saraiva, Claudia .
NPJ SYSTEMS BIOLOGY AND APPLICATIONS, 2025, 11 (01)
[44]   Long-Term Health of Dopaminergic Neuron Transplants in Parkinson's Disease Patients [J].
Hallett, Penelope J. ;
Cooper, Oliver ;
Sadi, Damaso ;
Robertson, Harold ;
Mendez, Ivar ;
Isacson, Ole .
CELL REPORTS, 2014, 7 (06) :1755-1761
[45]   Dexamethasone protects against dopaminergic neuron injury in mice model of Parkinson's disease [J].
Czlonkowska, A ;
Kurkowska-Jastrzebska, I ;
Joniec, I ;
Przybylkowski, A ;
Czlonkowski, A .
NEUROLOGY, 2001, 56 (08) :A342-A342
[46]   Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease [J].
Kim, Ji Hwan ;
Jeon, Jonghu ;
Lee, Young ;
Kim, Seung Min ;
Cheon, Miju ;
Kim, Jun Yup .
CLINICAL NUCLEAR MEDICINE, 2023, 48 (02) :143-149
[47]   Astrocytic JWA Expression is Essential to Dopaminergic Neuron Survival in the Pathogenesis of Parkinson's Disease [J].
Miao, Shu-Han ;
Sun, Hong-Bin ;
Ye, Yang ;
Yang, Jing-Jing ;
Shi, Yao-Wei ;
Lu, Ming ;
Hu, Gang ;
Zhou, Jian-Wei .
CNS NEUROSCIENCE & THERAPEUTICS, 2014, 20 (08) :754-762
[48]   Assessment of dopaminergic neuron degeneration in a C. elegans model of Parkinson's disease [J].
Palikaras, Konstantinos ;
Sengupta, Tanima ;
Nilsen, Hilde ;
Tavernarakis, Nektarios .
STAR PROTOCOLS, 2022, 3 (02)
[49]   Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss [J].
Annerino, Dana M. ;
Arshad, Shawn ;
Taylor, Georgia M. ;
Adler, Charles H. ;
Beach, Thomas G. ;
Greene, James G. .
ACTA NEUROPATHOLOGICA, 2012, 124 (05) :665-680
[50]   Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss [J].
Dana M. Annerino ;
Shawn Arshad ;
Georgia M. Taylor ;
Charles H. Adler ;
Thomas G. Beach ;
James G. Greene .
Acta Neuropathologica, 2012, 124 :665-680